Skip to main content

Rheumatology and Therapy

Ausgabe 3/2024

Inhalt (24 Artikel)

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data

  • Open Access
  • Commentary

Lars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D. Kinch, Dafna D. Gladman

Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study

  • Open Access
  • Original Research

Beatriz Frade-Sosa, Andrés Ponce, Estíbaliz Ruiz-Ortiz, Noemí De Moner, María J. Gómara, Ana Belén Azuaga, Juan C. Sarmiento-Monroy, Rosa Morlà, Virginia Ruiz-Esquide, Laura Macías, Nuria Sapena, Lola Tobalina, Julio Ramirez, Juan D. Cañete, Jordi Yague, Josep M. Auge, José A. Gomez-Puerta, Odette Viñas, Isabel Haro, Raimon Sanmarti

Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases

  • Open Access
  • Original Research

Ran Jin, Silvia Kruppert, Florian Scholz, Isabelle Bardoulat, Khalil Karzazi, Francois Morand, Greg Kricorian, David Collier, Jonathan Kay

The Evaluation of Effectiveness and Safety of Guselkumab in Patients with Psoriatic Arthritis in a Prospective Multicentre “Real-Life” Cohort Study

  • Open Access
  • Original Research

Piero Ruscitti, Giulia Cataldi, Martina Gentile, Alice Dionisi, Paola Volpe, Annacarla Finucci, Lucrezia Verardi, Claudia Di Muzio, Noemi Italiano, Eleonora Celletti, Myriam Di Penta, Ilenia Di Cola, Alessandra Marrelli, Alessia Alfonsi, Francesco Delle Monache, Francesco Cipollone, Marco Gabini, Paola Cipriani

Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study

  • Open Access
  • Original Research

Fabio Massimo Perrotta, Rossana Scrivo, Salvatore D’Angelo, Silvia Scriffignano, Andrea Delle Sedie, Laura Coates, Ennio Lubrano

Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study

  • Open Access
  • Original Research

Louis Bessette, Jonathan Chan, Andrew Chow, Larissa Lisnevskaia, Nicolas Richard, Pierre-Andre Fournier, Dalinda Liazoghli, Tanya Girard, Derek Haaland

Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies

  • Open Access
  • Original Research

Xenofon Baraliakos, Annette E. Szumski, Kenneth K. Kwok, Bonnie Vlahos, Cecilia E. Borlenghi

Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE

  • Open Access
  • Original Research

Roy Fleischmann, Ricardo Blanco, Filip Van den Bosch, Louis Bessette, Yanna Song, Sara K. Penn, Erin McDearmon-Blondell, Nasser Khan, Kelly Chan, Eduardo Mysler

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial

  • Open Access
  • Original Research

Lars Erik Kristensen, Mauro Keiserman, Kim Papp, Leslie McCasland, Douglas White, Kyle Carter, Ralph Lippe, Huzefa Photowala, Leonidas Drogaris, Ahmed M. Soliman, Michael Chen, Byron Padilla, Frank Behrens

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial

  • Open Access
  • Original Research

Andrew Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Kyle Carter, Vassilis Stakias, Ralph Lippe, Leonidas Drogaris, Ahmed M. Soliman, Michael M. Chen, Byron Padilla, Alan Kivitz

Long-Term Efficacy Following Intra-articular Injection of Carboxymethyl-chitosan, a New Product Class for Knee Osteoarthritis: Results from an Observational Study in Germany

  • Open Access
  • Original Research

Nils A. Lynen, Christoph Eichhorn, Nicolas Portelange, Mickaël Chausson, Wim Weyenberg

Clinical Characteristics of “Severe” Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort

  • Open Access
  • Original Research

Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta

Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies

  • Open Access
  • Original Research

Alan J. Kivitz, Joel M. Kremer, Clarence W. Legerton III, Luminita Pricop, Atul Singhal

Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial

  • Open Access
  • Original Research

Kurt de Vlam, Walter P. Maksymowych, Gaia Gallo, Proton Rahman, Philip Mease, Venkatesh Krishnan, Conor J. McVeigh, Jeffrey Lisse, Danting Zhu, Rebecca J. Bolce, Philip G. Conaghan

A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry

  • Open Access
  • Original Research

Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials

  • Open Access
  • Original Research

Gerd R. Burmester, Jayne Stigler, Andrea Rubbert-Roth, Yoshiya Tanaka, Valderilio F. Azevedo, Derek Coombs, Ivan Lagunes, Ralph Lippe, Peter Wung, Lianne S. Gensler

A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy Volunteers

  • Open Access
  • Original Research

Lyrialle W. Han, Samira Jamalian, Joy C. Hsu, X. Rebecca Sheng, Xiaoyun Yang, Xiaoying Yang, Sharareh Monemi, Sharmeen Hassan, Rajbharan Yadav, Katie Tuckwell, Rebecca Kunder, Lin Pan, Sara Glickstein

Elevating the Standard of Care for Patients with Axial Spondyloarthritis: ‘Calls to Action’ from Rheumacensus, a Multistakeholder Pan-European Initiative

  • Open Access
  • Original Research

Andri Phoka, Bart J. F. van den Bemt, Ennio Lubrano, Inderjit Singh, Cristina Fernández-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe, Laura Harrington, Xenofon Baraliakos

Elevating the Standard of Care for Patients with Psoriatic Arthritis: ‘Calls to Action’ from a Multistakeholder Pan-European Initiative

  • Open Access
  • Original Research

Iris Verbinnen, Emilio Monte-Boquet, Detlev Parow, Fabienne Lacombe, Andrew Pothecary, Arno W. R. van Kuijk, Laura Harrington, Edita Müllerová, Andreas Pinter, Ulrike Erstling, Andrea Tomasini, Philip S. Helliwell

Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison

  • Open Access
  • Brief Report

Philip J. Mease, Richard B. Warren, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Damon Willems, Vanessa Taieb, Jason Eells, Iain B. McInnes

Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison

  • Open Access
  • Brief Report

Richard B. Warren, Iain B. McInnes, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Damon Willems, Vanessa Taieb, Jason Eells, Philip J. Mease

Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting

  • Open Access
  • Brief Report

Joshua F. Baker, Catherine Bakewell, Ara Dikranian, Gordon Lam, Jacqueline O’Brien, Page C. Moore, Miao Yu, Peter Hur, Karim R. Masri

Current Use and Barriers to Point-of-Care Ultrasound in Rheumatology: A National Survey of VA Medical Centers

  • Open Access
  • Brief Report

Ayesha Iqbal, Madiha Ahmad, Kevin J. Murray, Jison Sim, Terry J. S. Lund, Anthony J. Andrade, Ariadna Perez-Sanchez, Michael J. Mader, Elizabeth K. Haro, Jason P. Williams, Robert Nathanson, Nilam J. Soni

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Krebsscreeningprogramme erreichen Menschen mit kognitiver Beeinträchtigung schlechter

Daten aus den Niederlanden zeigen, dass Krebsfrüherkennungsmaßnahmen für Menschen mit Störungen der Intelligenzentwicklung häufig nicht zugänglich sind. Wie kann diese Lücke geschlossen werden?

Perkutane Ablation – ungenutztes Potenzial für die Schmerztherapie?

Geht es nach US-Versicherungsdaten, ist die perkutane Ablation eine vorteilhafte, aber zu selten genutzte Option in der Schmerzlinderung von Personen mit bestimmten Tumoren. Wichtige Fragen bleiben allerdings unbeantwortet.

Reduzieren Kälte und Kompression die CIPN-Gefahr in den Händen?

Ergebnisse der deutschen POLAR-Studie sprechen dafür, dass kühlende oder komprimierende Handschuhe das Risiko für eine Taxan-induzierte periphere Neuropathie senken können. Ein paar Fragen bleiben aber offen.

Spricht eine hohe eGFR-Variabilität für eine ungünstige Prognose?

Variiert die geschätzte glomeruläre Filtrationsleistung von Messung zu Messung deutlich, ist das bei Menschen mit chronischer Niereninsuffizienz ein ungünstiges Zeichen, nicht nur mit Blick auf die Niere. Dafür spricht zumindest eine Auswertung der CRIC-Studie.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.